skip to main content

News Archive

Date: 01/23/2024
Equity in cancer care has long been an important theme for Lori Pierce, M.D. She made it a focus as president of the American Society of Clinical Oncology in 2021. So when the editors of The Cancer Journal selected health equity in cancer care as the topic for a recent special issue, Pierce, professor of radiation oncology at Michigan Medicine, was the ideal choice for guest editor.
Date: 01/15/2024
Lori J. Pierce, M.D., was one of 30 cancer scientists elected to the American Association for Cancer Research class of Fellows of the AACR Academy. Pierce was elected for illuminating contributions to establishing radiotherapy in the multimodality treatment of breast cancer, including intensity-modulated radiotherapy for node-positive breast cancer and incorporation of radiosensitizing agents, which have collectively resulted in improved treatment outcomes for breast cancer patients, most notably those harboring BRCA1/2 gene mutations.
Date: 01/12/2024
Researchers at the University of Michigan Health Rogel Cancer Center have identified a mechanism that causes severe gastrointestinal problems with immune-based cancer treatment. They also found a way to deliver immunotherapy’s cancer-killing impact without the unwelcome side effect.
Date: 01/09/2024
Research from Michigan Medicine experts is shedding light and potentially expanding options for patients living with medulloblastoma, an aggressive childhood cancer.
Date: 01/09/2024
Recently, Michigan Medicine became the first health care system in the Midwest to bring Recharge Rooms to its employees. These innovative, immersive mental health interventions were designed to support the well-being and resilience of the hospital’s health care workers.
Date: 12/31/2023
Within the last few years, nuclear medicine has added to cutting edge treatment options for cancer. One of the latest advancements is the use of a treatment called Pluvicto to treat metastatic castration-resistant prostate cancer.
Date: 12/19/2023
University of Michigan Health Rogel Cancer Center were included on the 2023 list of Highly Cited Researchers. Published by Clarivate Analytics, the annual list highlights researchers who have demonstrated significant and broad influence in their area of research and who have authored multiple papers ranked in the top 1% by citations in their field.
Date: 12/06/2023
Daniel F. Hayes, M.D., received the Brinker Award for Clinical Research from Susan G. Komen, the world’s leading breast cancer organization. The award recognizes physician-scientists for their work to drive discoveries and improve breast cancer patient outcomes.
Date: 12/06/2023
Three Rogel Cancer Center researchers have received new grants from the American Cancer Society for projects focused on cervical cancer screening, genetic testing and glioblastoma. The grants, which include a Research Scholar Grant to Diane Harper and two postdoctoral fellow grants, total $1.16 million.
Date: 12/06/2023
With a new $3.4 million grant from the National Cancer Institute, a team of Rogel Cancer Center researchers will develop new tools to detect changes in precancerous lesions that are likely to become oral cancers. When detected early, this type of head and neck cancer can be curable.

Pages